CapsoVision, Inc. — Earnings Quality Grade D
CV · Healthcare
Significant concerns
Screening Summary
Management Signals
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 67 days, change +5 days YoY
AR growth 24.8% exceeds revenue growth 15.3%
Revenue grew 15.3% but CFFO declined -13.8%
Small-cap context: Small-cap revenue/CFFO ratio is sensitive to growth-stage working-capital draws.
Expense Quality
Inventory 13.6% vs COGS 18.6%. Normal
CapEx growth -41.2% vs revenue 15.3%. Normal
SG&A/Gross Profit = 200.5%, exceeds 70%
Gross margin 52.9%, change -1.3pp. Stable
Cash Flow Quality
CFFO/NI = 0.90. Profits backed by cash
FCF is negative ($-0.0B)
Accruals ratio = -13.5%. Low accruals
Cash $0.0B covers debt $0.0B
Balance Sheet Health
No goodwill. Clean balance sheet
Debt/EBITDA = -0.0x. Healthy
Other assets 0.0% vs revenue 15.3%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions negative for 3 years
Small-cap context: A single acquisition on a small balance sheet can trip serial-acquirer logic.
No goodwill
Manipulation Score
M-Score = -3.38 (< -2.22). Unlikely manipulator
Portfolio monitoring
Monitor CV continuously
The full checks and model details are free to read. Use Watchlist to track your holdings; Pro adds automatic quarterly rescoring, risk-event email alerts, scans up to 50 tickers, and export workflows.
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25